Cell Growth & Differentiation, Vol 5, Issue 3 267-275, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression

S Hsu, F Huang, M Hafez, S Winawer and E Friedman
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Transforming growth factor beta 1 (TGF-beta 1) switches from an inhibitor of tumor cell growth to a stimulator of growth and invasion during human colon carcinoma progression. We originally observed that metastatic colon carcinoma cells in primary culture responded to TGF-beta 1 by proliferation, whereas moderate to well-differentiated primary site colon carcinomas were growth inhibited by TGF-beta 1 (P. Schroy et al., Cancer Res., 50: 261-265, 1990). We then cloned several colon carcinoma cell lines which modeled these responses to TGF-beta 1 and expressed TGF-beta 1 (M. M. Hafez et al., Cell Growth & Differ., 1: 617-626, 1990; 3: 753-762, 1992). Two of these colon carcinoma cell lines, U9 and HD3, which activate approximately equal amounts of TGF-beta 1 and express equal amounts of TGF-beta receptors, are now used to compare the effects of TGF-beta 1 in modulating invasive behavior. The U9 cell line exhibits autocrine-positive growth regulation in vitro by TGF-beta 1, whereas the HD3 cell line shows the opposite response, autocrine-negative regulation. Blocking endogenous TGF-beta 1 with isotype-specific antibody inhibited U9 cell growth because autocrine TGF-beta 1 acts as a mitogen for U9 cells. In contrast, antibody to TGF-beta 1 stimulated HD3 cell proliferation because autocrine TGF-beta 1 inhibits growth of these cells. U9 cells were 13-fold more invasive in vitro through a collagen I layer than HD3 cells.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A Wimmel, B Wiedenmann, and S Rosewicz Autocrine growth inhibition by transforming growth factor {beta}-1 (TGF{beta}-1) in human neuroendocrine tumour cells Gut, September 1, 2003; 52(9): 1308 - 1316. [Abstract] [Full Text]

				A. H. Palamakumbura, P. Sommer, and P. C. Trackman Autocrine Growth Factor Regulation of Lysyl Oxidase Expression in Transformed Fibroblasts J. Biol. Chem., August 15, 2003; 278(33): 30781 - 30787. [Abstract] [Full Text] [PDF]

				R. C. Bates and A. M. Mercurio Tumor Necrosis Factor-{alpha} Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids Mol. Biol. Cell, May 1, 2003; 14(5): 1790 - 1800. [Abstract] [Full Text] [PDF]

				Z. Yan, G.-Y. Kim, X. Deng, and E. Friedman Transforming Growth Factor beta 1 Induces Proliferation in Colon Carcinoma Cells by Ras-dependent, smad-independent Down-regulation of p21cip1 J. Biol. Chem., March 15, 2002; 277(12): 9870 - 9879. [Abstract] [Full Text] [PDF]

				X. Deng, S. Bellis, Z. Yan, and E. Friedman Differential Responsiveness to Autocrine and Exogenous Transforming Growth Factor (TGF) {beta}1 in Cells with Nonfunctional TGF-{beta} Receptor Type III Cell Growth Differ., January 1, 1999; 10(1): 11 - 18. [Abstract] [Full Text]

				S. Zhou, P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J. Le Dai, S. E. Kern, K. W. Kinzler, and B. Vogelstein Targeted deletion of Smad4 shows it is required for transforming growth factor beta  and activin signaling in colorectal cancer cells PNAS, March 3, 1998; 95(5): 2412 - 2416. [Abstract] [Full Text] [PDF]

				Z. Yan, X. Deng, M. Chen, Y. Xu, M. Ahram, B. F. Sloane, and E. Friedman Oncogenic c-Ki-ras but Not Oncogenic c-Ha-ras Up-regulates CEA Expression and Disrupts Basolateral Polarity in Colon Epithelial Cells J. Biol. Chem., October 31, 1997; 272(44): 27902 - 27907. [Abstract] [Full Text] [PDF]

				Z. Yan, X. Deng, and E. Friedman Oncogenic Ki-ras Confers a More Aggressive Colon Cancer Phenotype through Modification of Transforming Growth Factor-beta Receptor III J. Biol. Chem., January 5, 2001; 276(2): 1555 - 1563. [Abstract] [Full Text] [PDF]

				L. Ulloa and S. Tabibzadeh Lefty Inhibits Receptor-regulated Smad Phosphorylation Induced by the Activated Transforming Growth Factor-beta Receptor J. Biol. Chem., June 8, 2001; 276(24): 21397 - 21404. [Abstract] [Full Text] [PDF]